BRIEF-Genmab announces preliminary cervical cancer data from tisotumab vedotin phase I/II study
June 16, 2017 at 13:43 PM EDT
* Genmab announces preliminary cervical cancer data from tisotumab vedotin phase i/ii study
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.